Inventor · disambiguated record
Dongdong Chen
Also filed as: CHEN DONGDONG
13 granted patents·9 pending applications·32 citations·filing 2015–2024
88Inventor score
Top patents by PatentIndex Score
22 records- 0192US10618929B23-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2, 7-dione compounds for the treatment and prophylaxis of virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Apr 14, 2020·5 cites·22 claims
- 0292US9441008B23-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Sep 13, 2016·13 cites·54 claims
- 0389US10040815B23-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Aug 7, 2018·7 cites·18 claims
- 0486US11655249B2Indolizine derivatives and their application in medicineKIND PHARMACEUTICAL·Filed 2021·Granted May 23, 2023·2 cites·22 claims
- 0583US11708344B2Flavone derivatives for the treatment and prophylaxis of hepatitis B virus diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Jul 25, 2023·3 cites·29 claims
- 0676US11970495B2Indolizine derivatives and their application in medicineKIND PHARMACEUTICAL·Filed 2023·Granted Apr 30, 2024·0 cites·12 claims
- 0776US11945817B2Indolizine derivatives and their application in medicineKIND PHARMACEUTICAL·Filed 2023·Granted Apr 2, 2024·0 cites·14 claims
- 0875US11021478B2Indolizine derivatives and their application in medicineKIND PHARMACEUTICAL·Filed 2018·Granted Jun 1, 2021·2 cites·15 claims
- 0966US11180525B2Process for making 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2, 7-dione compounds useful for the treatment of virus infectionHOFFMANN LA ROCHE·Filed 2020·Granted Nov 23, 2021·0 cites·12 claims
- 1066US2024360126A1Pyrazolo[3,4-b]pyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1157US12486273B2Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Dec 2, 2025·0 cites·18 claims
- 1256US12012390B2Flavone compounds for the treatment and prophylaxis of hepatitis B virus diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Jun 18, 2024·0 cites·19 claims
- 1356US2023295109A1Pyridinone compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1455US2023279001A1Imidazo[1,2-a]pyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1551US2022388969A1Substituted 3,4-dihydroquinazoline for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1651US2022348549A1Quinazoline compounds for the treatment and prophylaxis of hepatitis b virus diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1749US10611748B2Xanthone derivatives for the treatment of hepatitis B virus diseaseHOFFMANN LA ROCHE·Filed 2018·Granted Apr 7, 2020·0 cites·31 claims
- 1847US2022213049A1Substituted chromen-4-one for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1945US2022169639A1N-containing chromen-4-one derivatives for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 2044US2022388972A1Chroman-4-one derivatives for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 2142US2023144399A1Quinoline compounds for the treatment and prophylaxis of hepatitis b virus diseaseHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2241US10000512B2Compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2017·Granted Jun 19, 2018·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Dongdong Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →